73 articles
announced (March 2021) that the first patient has been dosed in the Phase 1 multi-center clinical trial for CT-0508, studying the potential of chimeric ...
Stephen Brannan, Chief Medical Officer at Karuna Therapeutics discusses positive data recently published in the New England Journal of Medicine from the...
Lamont, President and Chief Operating Officer at Inteliquet™, a leader in clinical trial matching, discusses the impact COVID has had on clinical tria...
Samuel Lederman, obstetrician, gynecologist, and a founding member of Palm Beach Obstetrics & Gynecology, discusses the positive 12-week primary analysi...
Returned guest, Kent Thoelke, Chief Scientific Officer and Executive Vice President at PRA Health Sciences, a leading pharmaceutical service, healthcare...
Kent Thoelke, Chief Scientific Officer and Executive Vice President of PRA Health Sciences, a leading pharmaceutical service, healthcare data, and contr...
Justin Odegaard, VP of Clinical Development at Guardant Health discusses a new study published in "Nature Medicine" (Oct 2020) which finds that the Guar...
Jim Doherty, CRO at Sage Therapeutics discuss the three clinical trials, one major depressive disorder (MDD), one postpartum depression (PPD) and one Es...
Mei Mei Hu, JD, co-founder and co-CEO and Peter Diamandis, MD, co-founder and vice chairman at COVAXX, a division of United Biomedical, discuss UB-612, ...
Rahul Aras, CEO of Iterion Therapeutics, a clinical stage biotechnology company developing novel cancer therapeutics discusses the company's lead produc...